Brintellix
- Product NDC
- 64764-560
- 11-digit product format
- 647640560
- Labeler code
- 64764
- Product ID
- 64764-560_cc70d6dd-e54b-483d-83f5-762a6cce455a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- vortioxetine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Application
- NDA204447
- Marketing category
- NDA
- Marketing start
- 2013-10-02
- Marketing end
- 0000-00-00
- Substance
- VORTIOXETINE HYDROBROMIDE
- Active strength
- 10 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 64764-560 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 64764-560 | 64764-560-07 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 64764-560 | 64764-560-09 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 64764-560 | 64764-560-30 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 64764-560 | 64764-560-77 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 64764-560 | 64764-560-90 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 64764-560-90 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 64764-560-09 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 64764-560-07 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 64764-560-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 64764-560-77 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 64764-560-90 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 64764-560-09 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 64764-560-07 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 64764-560-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 64764-560-77 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 64764-560-90 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 64764-560-09 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 64764-560-07 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 64764-560-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 64764-560-77 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 64764-560-90 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 64764-560-09 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 64764-560-07 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 64764-560-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 64764-560-77 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 64764-560-90 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 64764-560-09 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 64764-560-07 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 64764-560-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 64764-560-77 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 64764-560-90 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 64764-560-09 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 64764-560-07 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 64764-560-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 64764-560-77 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 64764-560-90 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 64764-560-09 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 64764-560-07 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 64764-560-30 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 64764-560-77 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 64764-560-90 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 64764-560-09 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 64764-560-07 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 64764-560-30 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 64764-560-77 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 64764-560-90 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 64764-560-09 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 64764-560-07 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 64764-560-30 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 64764-560-77 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 64764-560-90 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 64764-560-09 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 64764-560-07 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 64764-560-30 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 64764-560-77 | ad56d346431e… | cc804d4bbf1e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204447-001 | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | |
| N204447-002 | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | |
| N204447-003 | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | |
| N204447-004 | TRINTELLIX | VORTIOXETINE HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204447-001 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 |
| N204447-001 | 7144884*PED | 2026-12-17 | Pediatric extension | ||
| N204447-001 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 |
| N204447-001 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | |
| N204447-001 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-001 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-001 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-001 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | |
| N204447-001 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | |
| N204447-001 | 11458134*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 8969355*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 9125908*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 9125909*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 9125910*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 9227946*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 9861630*PED | 2027-12-15 | Pediatric extension | ||
| N204447-001 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | |
| N204447-001 | 8722684*PED | 2031-12-30 | Pediatric extension | ||
| N204447-001 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | |
| N204447-001 | 9278096*PED | 2032-09-21 | Pediatric extension | ||
| N204447-002 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 |
| N204447-002 | 7144884*PED | 2026-12-17 | Pediatric extension | ||
| N204447-002 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 |
| N204447-002 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | |
| N204447-002 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-002 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-002 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-002 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | |
| N204447-002 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | |
| N204447-002 | 11458134*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 8969355*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 9125908*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 9125909*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 9125910*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 9227946*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 9861630*PED | 2027-12-15 | Pediatric extension | ||
| N204447-002 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | |
| N204447-002 | 8722684*PED | 2031-12-30 | Pediatric extension | ||
| N204447-002 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | |
| N204447-002 | 9278096*PED | 2032-09-21 | Pediatric extension | ||
| N204447-003 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 |
| N204447-003 | 7144884*PED | 2026-12-17 | Pediatric extension | ||
| N204447-003 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 |
| N204447-003 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | |
| N204447-003 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-003 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-003 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-003 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | |
| N204447-003 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | |
| N204447-003 | 11458134*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 8969355*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 9125908*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 9125909*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 9125910*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 9227946*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 9861630*PED | 2027-12-15 | Pediatric extension | ||
| N204447-003 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | |
| N204447-003 | 8722684*PED | 2031-12-30 | Pediatric extension | ||
| N204447-003 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | |
| N204447-003 | 9278096*PED | 2032-09-21 | Pediatric extension | ||
| N204447-004 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 |
| N204447-004 | 7144884*PED | 2026-12-17 | Pediatric extension | ||
| N204447-004 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 |
| N204447-004 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | |
| N204447-004 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-004 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-004 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | |
| N204447-004 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | |
| N204447-004 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | |
| N204447-004 | 11458134*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 8969355*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 9125908*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 9125909*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 9125910*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 9227946*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 9861630*PED | 2027-12-15 | Pediatric extension | ||
| N204447-004 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | |
| N204447-004 | 8722684*PED | 2031-12-30 | Pediatric extension | ||
| N204447-004 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | |
| N204447-004 | 9278096*PED | 2032-09-21 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N204447-001 | M-232 | 2026-08-23 |
| N204447-001 | PED | 2027-02-23 |
| N204447-002 | M-232 | 2026-08-23 |
| N204447-002 | PED | 2027-02-23 |
| N204447-003 | M-232 | 2026-08-23 |
| N204447-003 | PED | 2027-02-23 |
| N204447-004 | M-232 | 2026-08-23 |
| N204447-004 | PED | 2027-02-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204447-001 | TRINTELLIX | EQ 5MG BASE | TABLET / ORAL | RLD | 2013-09-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204447-002 | TRINTELLIX | EQ 10MG BASE | TABLET / ORAL | RLD | 2013-09-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204447-003 | TRINTELLIX | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2013-09-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204447-004 | TRINTELLIX | EQ 20MG BASE | TABLET / ORAL | RLD, RS | 2013-09-30 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N204447-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N204447-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N204447-004 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N204447-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N204447-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N204447-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N204447-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N204447-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N204447-004 | AB | 1 | 782e0a99824c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 7144884*PED | 2026-12-17 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 11458134*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 8969355*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125908*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125909*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9125910*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9227946*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9861630*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 8722684*PED | 2031-12-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | 9278096*PED | 2032-09-21 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 7144884 | 2026-06-17 | U-1439 | Drug substance, Drug product | 2013-10-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 7144884*PED | 2026-12-17 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 11458134 | 2027-06-15 | U-3463 | Drug product | 2022-11-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 8969355 | 2027-06-15 | U-1668 | 2015-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125908 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125909 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125910 | 2027-06-15 | U-2309 | 2018-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9227946 | 2027-06-15 | U-1668 | 2016-01-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9861630 | 2027-06-15 | U-1668 | 2018-01-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 11458134*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 8969355*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125908*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125909*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9125910*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9227946*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9861630*PED | 2027-12-15 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 8722684 | 2031-06-30 | Drug substance, Drug product | 2014-06-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 8722684*PED | 2031-12-30 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9278096 | 2032-03-21 | U-2436 | 2018-11-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | 9278096*PED | 2032-09-21 | Pediatric extension | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | M-232 | 2026-08-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-001 | PED | 2027-02-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | M-232 | 2026-08-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-002 | PED | 2027-02-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-003 | M-232 | 2026-08-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-003 | PED | 2027-02-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-004 | M-232 | 2026-08-23 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204447-004 | PED | 2027-02-23 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-001 | M-232 | 2026-08-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-001 | PED | 2027-02-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-002 | M-232 | 2026-08-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-002 | PED | 2027-02-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-003 | M-232 | 2026-08-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-003 | PED | 2027-02-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-004 | M-232 | 2026-08-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204447-004 | PED | 2027-02-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-001 | M-232 | 2026-08-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-001 | PED | 2027-02-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-002 | M-232 | 2026-08-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-002 | PED | 2027-02-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-003 | M-232 | 2026-08-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-003 | PED | 2027-02-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-004 | M-232 | 2026-08-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204447-004 | PED | 2027-02-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-001 | M-232 | 2026-08-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-001 | PED | 2027-02-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-002 | M-232 | 2026-08-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-002 | PED | 2027-02-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-003 | M-232 | 2026-08-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-003 | PED | 2027-02-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-004 | M-232 | 2026-08-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204447-004 | PED | 2027-02-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-001 | M-232 | 2026-08-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-001 | PED | 2027-02-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-002 | M-232 | 2026-08-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-002 | PED | 2027-02-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-003 | M-232 | 2026-08-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-003 | PED | 2027-02-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-004 | M-232 | 2026-08-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204447-004 | PED | 2027-02-23 | fd3edfee7708… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64764-560-30 | EA - Each | 64764-560 | 00794264-8d41-43e3-9b9a-7667b6a54b2a | 1 | 2013-11-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trintellix | VORTIOXETINE | REMEDYREPACK INC. | 239215eb-be32-4286-9677-1e5556c6cccf | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | 204447 NDA204447 |
| Trintellix | VORTIOXETINE | REMEDYREPACK INC. | bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | 204447 NDA204447 |
| Trintellix | VORTIOXETINE | Cardinal Health 107, LLC | cb1e9df4-dd74-4073-9d78-bb55593dd000 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | 204447 NDA204447 |
| Trintellix | VORTIOXETINE | Takeda Pharmaceuticals America, Inc. | 1a5b68e2-14d0-419d-9ec6-1ca97145e838 | 2025-03-05 | Boxed warning, Warnings, Adverse reactions | 204447 NDA204447 |